Cromwell Holdings’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
WA
CAM
RP
PCM
EOJOAM
CF
MNBTD
COPPSERS
Cromwell Holdings's RGEN Position: Q2 2026 in Review
Cromwell Holdings increased its Repligen (RGEN) stake by 83% in Q2 2026, buying an estimated $614 and bringing the position to 11 shares worth $1.5K. The position accounts for ﹤0.01% of the portfolio, ranked #909.
Cromwell Holdings first reported a position in RGEN in Q1 2025 and has held it in 6 quarters since. 48 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Cromwell Holdings held 11 shares of Repligen worth $1.5K as of Q2 2026.
- Cromwell Holdings bought 5 Repligen shares in Q2 2026, an estimated $614.
- Repligen made up ﹤0.01% of Cromwell Holdings's portfolio in Q2 2026, its #909 holding.
- Cromwell Holdings first reported a position in Repligen in Q1 2025 and has held it in 6 quarters since.
- 48 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.